Skip to main content
SpringerLink
Log in

Effects of the atrial antiarrhythmic drug AVE0118 on cardiac ion channels

  • Original Article
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

Previous studies in pigs and goats have demonstrated that AVE0118 prolongs atrial refractoriness without any effect on the QT-interval. The purpose of the present study was to investigate the effect of the compound on various cardiac ion channels. AVE0118 blocked the pig Kv1.5 and the human Kv1.5 expressed in Xenopus oocytes with IC50 values of 5.4±0.7 μM and 6.2±0.4 μM respectively. In Chinese hamster ovary (CHO) cells, AVE0118 decreased the steady-state hKv1.5 current with an IC50 of 1.1±0.2 μM. The hKv4.3/KChIP2.2 current in CHO cells was blocked by AVE0118 by accelerating the apparent time-constant of inactivation (τinact), and the integral current was inhibited with an IC50 of 3.4±0.5 μM. At 10 μM AVE0118 τinact decreased from 9.3±0.6 ms (n=8, control) to 3.0±0.3 ms (n=8). The KACh current was investigated in isolated pig atrial myocytes by application of 10 μM carbachol. At a clamp potential of −100 mV the IKACh was half-maximally blocked by 4.5±1.6 μM AVE0118. In the absence of carbachol, AVE0118 had no effect on the inward current recorded at −100 mV. Effects on the IKr current were investigated on HERG channels expressed in CHO cells. AVE0118 blocked this current half-maximally at approximately 10 μM. Comparable results were obtained in isolated guinea pig ventricular myocytes, where half-maximal inhibition of the IKr tail current occurred at a similar concentration of AVE0118. Other ionic currents, like the IKs, IKATP (recorded in guinea pig ventricular myocytes), and L-type Ca2+ (recorded in pig atrial myocytes) were blocked by 10 μM AVE0118 by 10±3% (n=6), 28±7% (n=4), and 22±13% (n=5) respectively. In summary, AVE0118 preferentially inhibits the atrial K+ channels IKur, Ito and IKACH. This profile may explain the selective prolongation of atrial refractoriness described previously in pigs and goats.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

  • Amos GJ, Wettwer E, Metzger F, Li Q, Himmel HM, Ravens U (1996) Differences between outward currents of human atrial and subepicardial ventricular myocytes. J Physiol (Lond) 491:31–50

    CAS  Google Scholar 

  • An WF, Bowlby MR, Betty M, Cao J, Ling H-P, Mendoza G, Hinson JW, Mattson KI, Strassle BW, Trimmer JS, Rhodes KJ (2000) Modulation of A-type potassium channels by a family of calcium sensors. Nature 403:553–556

    CAS  PubMed  Google Scholar 

  • Bachmann A, Gutcher I, Kopp K, Brendel J, Bosch RF, Busch AE, Gogelein H (2001) Characterization of a novel Kv1.5 channel blocker in Xenopus oocytes, CHO cells, human and rat cardiomyocytes. Naunyn-Schmiedebergs Arch Pharmacol 364:472–478

    Article  CAS  PubMed  Google Scholar 

  • Barry DM, Nerbonne JM (1996) Myocardial potassium channels: electrophysiological and molecular diversity. Annu Rev Physiol 58:363–394

    Article  CAS  PubMed  Google Scholar 

  • Blaauw Y, Gögelein H, Tieleman RG, van Hunnink A, Schotten U, Allessie M (2004) ‘Early’ class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat. Circulation (in press)

  • Bosch RF, Nattel S (2002) Cellular electrophysiology of atrial fibrillation. Cardiovasc Res 54:259–269

    Article  CAS  PubMed  Google Scholar 

  • Bosch R, Lazlo R, Schneck AC, Gögelein H, Bleich M, Mewis C, Kuhlkamp V (2002) AVE0118, an antiarrhythmic drug with novel mechanism of action-Block of IKur and Ito potassium currents in human atrial myocytes. Circulation 106:108

    Google Scholar 

  • Brendel J, Peukert S (2002) Blockers of the Kv1.5 channel for the treatment of atrial arrhythmias. Expert Opin Ther Patents 12:1589–1598

    Article  CAS  Google Scholar 

  • Decher N, Uyguner O, Scherer CR, Karaman B, Yüksel-Apak M, Busch AE, Steinmeyer K, Wollnik B (2001) hKChIP2 is a functional modifier of hKv4.3 potassium channels: cloning and expression of a short hKChIP2 splice variant. Cardiovasc Res 52:255–264

    CAS  PubMed  Google Scholar 

  • Dilks D, Ling H-P, Cockett M, Sokol P, Numann R (1999) Cloning and expression of the human Kv4.3 potassium channel. J Neurophysiol 81:1974–1977

    CAS  PubMed  Google Scholar 

  • Dixon JE, Shi W, Wang H-S, McDonald C, Yu H, Wymore RS, Cohen IS, McKinnon D (1996) Role of the Kv4.3 K+ channel in ventricular muscle. A molecular correlate for the transient outward current. Circ Res 79:659–668

    CAS  PubMed  Google Scholar 

  • Dobrev D, Ravens U (2003) Remodeling of cardiomyocyte ion channels in human atrial fibrillation. Basic Res Cardiol 98:137–148

    PubMed  Google Scholar 

  • Dukes ID, Cleemann L, Morad M (1990) Tedisamil blocks the transient and delayed rectifier K+ currents in mammalian cardiac and glial cells. J Pharmacol Exp Ther 254:560–569

    CAS  PubMed  Google Scholar 

  • Falk RH (1989) Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation. Ann Intern Med 111:107–111

    CAS  PubMed  Google Scholar 

  • Fedida D, Wible B, Wang Z, Fermini B, Faust F, Nattel S, Brown AM (1993) Identity of a novel delayed rectifier current from human heart with a cloned K+ channel current. Circ Res 73:210–216

    CAS  PubMed  Google Scholar 

  • Feld GK (1990) Atrial fibrillation: is there a safe and highly effective pharmacological treatment? Circulation 90:2032–2040

    Google Scholar 

  • Feng JL, Wible B, Li GR, Wang ZG, Nattel S (1997) Antisense oligodeoxynucleotides directed against Kv1.5 mRNA specifically inhibit ultrarapid delayed rectifier K+ current in cultured adult human atrial myocytes. Circ Res 80:572–579

    CAS  PubMed  Google Scholar 

  • Gögelein H, Hartung J, Englert HC, Schölkens BA (1998) HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. I. Effects on cardiomyocytes, coronary flow and pancreatic β-cells. J Pharmacol Exp Ther 286:1453–1464

    PubMed  Google Scholar 

  • Gögelein H, Brendel J, Busch AE, Bleich M (2004) Effects of AVE0118, a novel inhibitor of atrial K+ channels, on action potentials in isolated atria. Naunyn-Schmiedebergs Arch Pharmacol 369:R67

    Google Scholar 

  • Hamill OP, Marty M, Neher E, Sakmann B, Sigworth FJ (1981) Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 391:85–100

    CAS  PubMed  Google Scholar 

  • Hart RG, Halpertin JL (2001) Atrial fibrillation and stroke. Concepts and controversies. Stroke 32:803–808

    CAS  PubMed  Google Scholar 

  • Kannel WB, Abbot RD, Savage DD, McNamara PM (1982) Epidemiologic features of chronic atrial fibrillation. The Framingham Study. N Engl J Med 306:1018–1022

    CAS  PubMed  Google Scholar 

  • Knobloch K, Brendel J, Peukert S, Rosenstein B, Busch AE, Wirth KJ (2002) Electrophysiological and antiarrhythmic effects of the novel I(Kur) channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the I(Kr) blockers dofetilide, azimilide, d,l-sotalol and ibutilide. Naunyn-Schmiedebergs Arch Pharmacol 366:482–487

    Article  CAS  PubMed  Google Scholar 

  • Krause E, Englert H, Gögelein H (1995) Adenosine triphosphate-dependent K currents activated by metabolic inhibition in rat ventricular myocytes differ from those elicited by the channel opener rilmakalim. Pflugers Arch 429:625–635

    CAS  PubMed  Google Scholar 

  • Li GR, Feng J, Yue L, Carrier M, Nattel S (1996) Evidence for two components of delayed rectifier K+ current in human ventricular myocytes. Circ Res 78:689–696

    CAS  PubMed  Google Scholar 

  • Middlekauf HR, Stevenson WG, Stevenson LW (1991) Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation 84:40–48

    PubMed  Google Scholar 

  • Nagasawa H, Fujiki A, Fujikura N, Matsuda T, Yamashita T, Inoue H (2002) Effects of a novel class III antiarrhythmic agent, NIP-142, on canine atrial fibrillation and flutter. Circ J 66:185–191

    Article  CAS  PubMed  Google Scholar 

  • Ohya S, Morohashi Y, Muraki K, Tomita T, Watanabe M, Iwatsubo T, Imaizumi Y (2001) Molecular cloning and expression of the novel splice variants of K+ channel-interacting protein 2. Biochem Biophys Res Commun 282:96–102

    Article  CAS  PubMed  Google Scholar 

  • Rampe D, Roy ML, Dennis A, Brown AM (1997) A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG. FEBS Lett 417:28–32

    Article  CAS  PubMed  Google Scholar 

  • Seki A, Hagiwara N, Kasanuki H (2002) Effects of NIP-141 on K currents in human atrial myocytes. J Cardiovasc Pharmacol 39:29–38

    Article  CAS  PubMed  Google Scholar 

  • Singh S, Zoble RG, Yellen L, Brodsky MA, Feld GK, Berk M, Billing CB (2000) Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter—the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study. Circulation 102:2385–2390

    CAS  PubMed  Google Scholar 

  • Tamkun MM, Knoth KM, Walbridge JA, Kroemer H, Roden DM, Glover DM (1991) Molecular cloning and characterization of two voltage-gated K+ channel cDNAs from human ventricle. FASEB J 5:331–337

    CAS  PubMed  Google Scholar 

  • Torp PC, Moller M, Bloch TP, Kober L, Sandoe E, Egstrup K, Agner E, Carlsen J, Videbaek J, Marchant B, Camm AJ (1999) Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish investigations of arrhythmia and mortality on dofetilide study group. N Engl J Med 341:857–865

    Article  PubMed  Google Scholar 

  • Villmann C, Bull L, Hollmann M (1997) Kainate binding proteins possess functional ion channel domains. J Neurosci 17:7634–7643

    Google Scholar 

  • Waldo AL, Camm AJ, deRuyter H, Friedmann PL, MacNeil DJ, Pauls JF, Pitt B, Pratt CM, Schwartz PJ, Veltri EP (1996) Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD investigation. Survival with oral d-sotalol. Lancet 348:7–12

    Article  CAS  PubMed  Google Scholar 

  • Wang Z, Fermini B, Nattel S (1993) Sustained depolarization-induced outward current in human atrial myocytes. Evidence for a novel delayed rectifier K+ current similar to Kv1.5 cloned channel currents. Circ Res 73:1061–1076

    CAS  PubMed  Google Scholar 

  • Wang Z, Fermini B, Nattel S (1995) Effects of flecainide, quinidine, and 4-aminopyridine on transient outward and ultrarapid delayed rectifier currents in human atrial myocytes. J Pharmacol Exp Ther 272:184–196

    CAS  PubMed  Google Scholar 

  • Wettwer E, Hála O, Christ T, Heubach JF, Dobrev D, Knaut M, Varró A, Ravens U (2004) Role of IKur in controlling action potential shape and contractility in the human atrium: influence of chronic atrial fibrillation. Circulation (in press)

    Google Scholar 

  • Wirth KJ, Knobloch K (2001) Differential effects of dofetilide, amiodarone, and class Ic drugs on left and right atrial refractoriness and left atrial vulnerability in pigs. Naunyn-Schmiedebergs Arch Pharmacol 363:166–174

    Article  CAS  PubMed  Google Scholar 

  • Wirth KJ, Paehler T, Rosenstein B, Knobloch K, Maier T, Frenzel J, Brendel J, Busch AE, Bleich M (2003) Atrial effects of the novel K+-channel-blocker AVE0118 in anesthetized pigs. Cardiovasc Res 60:298–306

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Aventis Pharma Deutschland GmbH, Industriepark Hoechst, H821, 65926, Frankfurt/Main, Germany

    Heinz Gögelein, J. Brendel, K. Steinmeyer, C. Strübing, N. Picard, D. Rampe, K. Kopp, A. E. Busch & M. Bleich

Authors
  1. Heinz Gögelein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Brendel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Steinmeyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Strübing
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N. Picard
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D. Rampe
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. K. Kopp
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A. E. Busch
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M. Bleich
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Heinz Gögelein.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gögelein, H., Brendel, J., Steinmeyer, K. et al. Effects of the atrial antiarrhythmic drug AVE0118 on cardiac ion channels. Naunyn-Schmiedeberg's Arch Pharmacol 370, 183–192 (2004). https://doi.org/10.1007/s00210-004-0957-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00210-004-0957-y

Keywords

Search

Navigation